A solid tumor next-generation sequencing assay for biomarker analysis
The Oncomine Focus Assay is a targeted, multi-biomarker assay that enables detection of hotspots, SNVs, indels, CNVs, and gene fusions from DNA and RNA in a single workflow. This comprehensive assay design is further enhanced with workflow automation, delivering insights quickly and helping accelerate your research towards that next companion diagnostic or therapy in the future.
Designed for clinical and translational cancer research, the Oncomine Focus Assay leverages proprietary Ion AmpliSeq technology to enable robust results, low input amounts, and analysis of low quality samples, and is compatible with FFPE fine needle aspirates and core needle biopsies.
Content
Simultaneous detection of hundreds of variants across 52 genes relevant to solid tumors.
- Targets relevant hotspots, SNVs, indels, CNVs, and gene fusions from DNA or RNA in a single workflow
- Enables detection of NTRK1, NTRK2, and NTRK3 gene fusions
- Includes solid tumor genes targeted by on-market oncology drugs and published evidence
- Content driven by the Oncomine Knowledgebase, which includes content aligned to relevant evidence
Oncomine Focus Assay gene list
Hotspot genes | |
---|---|
AKT1
| IDH2 |
Copy number genes | |
---|---|
AKT1 | PIK3CA |
Gene fusions | |
---|---|
ABL1
| PDGFRA |
A 3-day NGS workflow from tissue sample to report
Prep
From FFPE samples including fine needle aspirates and needle biopsies, DNA and RNA is extracted, amplified, and templated into amplicon-based libraries ready to be sequenced.
Sequence
Ion GeneStudio S5 Series enables high-throughput sequencing of 2M to 130M reads per run.
Analyze
Seamless integration of our informatics solutions with our sequencing platforms enable quick and intuitive analysis and reporting.
Sample extraction
From FFPE samples including fine needle aspirates and needle biopsies, DNA and RNA is extracted, amplified, and templated into amplicon-based libraries ready to be sequenced.
Library preparation
Oncomine Focus Assay is a targeted, multi-biomarker NGS assay that enables analysis on all classes of variants from DNA and RNA across 52 unique genes in a single workflow.
Library templating
The Ion Chef System enables hands-free library templating of the Oncomine libraries into the Ion Chip for downstream sequencing.
The Ion GeneStudio S5 Series enable throughput capacity from 2 million to 130 million reads per run. Simply select the Ion Chip that provides the throughput and coverage needed for your application.
Torrent Suite
Plan, monitor, and track your runs all within a web interface while reviewing the quality and accuracy of your sequencing run, in addition to variant calling, detecting SNPs and indels.
Ion Reporter
Call and annotate SNPs/InDels, CNVs, and fusions. Interpret your DNA and RNA variants faster and more easily from semiconductor sequencing data using a web-enabled solution.
Oncomine Reporter
With Ion Torrent Oncomine Reporter, get clear and concise reports that link biomarkers to relevant evidence.
Prep
From FFPE samples including fine needle aspirates and needle biopsies, DNA and RNA is extracted, amplified, and templated into amplicon-based libraries ready to be sequenced.
Sequence
Ion GeneStudio S5 Series enables high-throughput sequencing of 2M to 130M reads per run.
Analyze
Seamless integration of our informatics solutions with our sequencing platforms enable quick and intuitive analysis and reporting.
Sample extraction
From FFPE samples including fine needle aspirates and needle biopsies, DNA and RNA is extracted, amplified, and templated into amplicon-based libraries ready to be sequenced.
Library preparation
Oncomine Focus Assay is a targeted, multi-biomarker NGS assay that enables analysis on all classes of variants from DNA and RNA across 52 unique genes in a single workflow.
Library templating
The Ion Chef System enables hands-free library templating of the Oncomine libraries into the Ion Chip for downstream sequencing.
The Ion GeneStudio S5 Series enable throughput capacity from 2 million to 130 million reads per run. Simply select the Ion Chip that provides the throughput and coverage needed for your application.
Torrent Suite
Plan, monitor, and track your runs all within a web interface while reviewing the quality and accuracy of your sequencing run, in addition to variant calling, detecting SNPs and indels.
Ion Reporter
Call and annotate SNPs/InDels, CNVs, and fusions. Interpret your DNA and RNA variants faster and more easily from semiconductor sequencing data using a web-enabled solution.
Oncomine Reporter
With Ion Torrent Oncomine Reporter, get clear and concise reports that link biomarkers to relevant evidence.
Comparison of Oncomine assay and Ion AmpliSeq panel content
Targeted next-generation sequencing (NGS) is empowering laboratories of all sizes to confidently pioneer breakthroughs in cancer research. At the core of these breakthroughs are assays and panels designed to achieve highly sensitive results from minimal sample input—to help deliver information that may lead to the next companion diagnostic test or therapy in the future.
Clinical cancer research requires countless decisions. Of critical importance are the decisions you make about assay content. The Oncomine Focus Assay provides a robust assay where all genes provide actionable insights across a range of different cancer types.
Performance
- Reproducible and sensitive detection of variants across multiple cancer types
- Compatible with as little as 10 ng sample, including FFPE fine needle biopsies and core needle aspirates
- Enables results from up to six samples and two controls per run for DNA and RNA in a single workflow
- NGS results in days rather than weeks, leveraging Ion Torrent sequencing technology, optional Ion Chef library preparation, and the Ion GeneStudio S5 Systems
Analytical performance summary
Across variant types, the Oncomine Focus Assay achieves high sensitivity, specificity, and reproducibility using clinical research samples sequenced on the Ion GeneStudio S5 System.
Sensitivity | PPV (Specificity) | Reproducibility | |
SNVs | 98.77% | 99.63% | 99.6% |
Indels | 100% | 100% | 100% |
CNVs | 96.42% | 100% | 96.42% |
Gene fusion | 100% | 100% | 100% |
Overall | 98.70% | 99.67% | 99.01% |
Reporting
Features enabled with Oncomine informatics:
- Prioritize variants, find the relevant few
- Call variants, identify and annotate cancer drivers
- Quickly create custom, lab-generated reports
- Customizable report templates available in 11 languages
For Research Use Only. Not for use in diagnostic procedures.